| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Colm M. O'Tuathaigh | Q73600463 |
| Jennifer Stokes | Q95992523 | ||
| Paula Moran | Q42855300 | ||
| P2093 | author name string | Lieve Desbonnet | |
| John Waddington | |||
| Gavin Bock | |||
| Julia Marr | |||
| P2860 | cites work | Adolescent Cannabinoid Exposure Induces a Persistent Sub-Cortical Hyper-Dopaminergic State and Associated Molecular Adaptations in the Prefrontal Cortex. | Q52308392 |
| Schizophrenia | Q55868331 | ||
| Schizophrenia and the influenza epidemics of 1954, 1957 and 1959: A southern hemisphere study | Q57403506 | ||
| Advancing paternal and maternal age are both important for autism risk | Q59640156 | ||
| Behavioural sensitization to daily life stress in psychosis | Q60620912 | ||
| Gene–environment interaction on cognition: A twin study of childhood maltreatment and COMT variability | Q61890778 | ||
| A genome-wide CNV analysis of schizophrenia reveals a potential role for a multiple-hit model | Q63869335 | ||
| Sandy: a new mouse model for platelet storage pool deficiency | Q68038207 | ||
| Neurobiology of schizophrenia | Q79173267 | ||
| Endophenotyping schizophrenia | Q80257101 | ||
| Interleukin-1 beta gene polymorphism and its interactions with neuregulin-1 gene polymorphism are associated with schizophrenia | Q81366042 | ||
| Genetics of psychosis; insights from views across the genome | Q22252693 | ||
| Rare chromosomal deletions and duplications increase risk of schizophrenia | Q22337245 | ||
| Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling | Q24322974 | ||
| The dysbindin-containing complex (BLOC-1) in brain: developmental regulation, interaction with SNARE proteins and role in neurite outgrowth | Q24338919 | ||
| Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia | Q24532517 | ||
| Schizophrenia and affective disorders--cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. | Q24535773 | ||
| Biological insights from 108 schizophrenia-associated genetic loci | Q24561833 | ||
| In vivo and in vitro genetic evidence of involvement of neuregulin 1 in immune system dysregulation | Q24610713 | ||
| Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia | Q24612644 | ||
| Neuregulin 1 and susceptibility to schizophrenia | Q24616921 | ||
| D2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHD | Q24627768 | ||
| Rate of de novo mutations and the importance of father's age to disease risk | Q24632353 | ||
| Membrane fusion: grappling with SNARE and SM proteins | Q24633113 | ||
| Prenatal infection as a risk factor for schizophrenia | Q24644310 | ||
| Neurexin 1 (NRXN1) deletions in schizophrenia | Q24649863 | ||
| Maternal immune activation alters fetal brain development through interleukin-6. | Q24653759 | ||
| Aberrant epigenetic regulation could explain the relationship of paternal age to schizophrenia | Q24653951 | ||
| Large recurrent microdeletions associated with schizophrenia | Q24654741 | ||
| Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia | Q26822851 | ||
| Genome-scale neurogenetics: methodology and meaning | Q26859474 | ||
| Phenotypic characterization of transgenic mice overexpressing neuregulin-1 | Q27316077 | ||
| Maternal immune activation leads to selective functional deficits in offspring parvalbumin interneurons | Q27319478 | ||
| Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies | Q28190066 | ||
| Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review | Q28238516 | ||
| Causal association between cannabis and psychosis: examination of the evidence | Q28241735 | ||
| A frameshift mutation in Disrupted in Schizophrenia 1 in an American family with schizophrenia and schizoaffective disorder | Q28254976 | ||
| Psychiatric genetics: progress amid controversy | Q28284253 | ||
| Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology | Q28294217 | ||
| Effects of antipsychotics on the behavioral deficits in human dominant-negative DISC1 transgenic mice with neonatal polyI:C treatment. | Q48952800 | ||
| Abnormal trajectories of neurodevelopment and behavior following in utero insult in the rat. | Q48963190 | ||
| Preliminary evidence for association between schizophrenia and polymorphisms in the regulatory Regions of the ADRA2A, DRD3 and SNAP-25 Genes. | Q49090131 | ||
| Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes. | Q50508007 | ||
| Cannabis use in young people: the risk for schizophrenia. | Q50631098 | ||
| COMT Val158Met-stress interaction in psychosis: role of background psychosis risk. | Q50658201 | ||
| A positive correlation between serum levels of mature brain-derived neurotrophic factor and negative symptoms in schizophrenia. | Q50668491 | ||
| Maternal immune activation during gestation interacts with Disc1 point mutation to exacerbate schizophrenia-related behaviors in mice. | Q50746247 | ||
| Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. | Q51738410 | ||
| Misconceptions about gene-environment interactions in psychiatry. | Q51847074 | ||
| Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk. | Q51894967 | ||
| Immunological stress at the maternal-foetal interface: a link between neurodevelopment and adult psychopathology. | Q51922940 | ||
| Cannabis dependence and psychotic symptoms in young people | Q52024293 | ||
| America's Cannabis Experiment. | Q52150517 | ||
| Novel molecular changes induced by Nrg1 hypomorphism and Nrg1-cannabinoid interaction in adolescence: a hippocampal proteomic study in mice | Q36637155 | ||
| A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition | Q36657533 | ||
| A critical period of vulnerability to adolescent stress: epigenetic mediators in mesocortical dopaminergic neurons | Q36676822 | ||
| Cannabis and psychosis: an update on course and biological plausible mechanisms | Q36728397 | ||
| BDNF-Deficient Mice Show Reduced Psychosis-Related Behaviors Following Chronic Methamphetamine | Q36852389 | ||
| Dissecting cause and effect in the pathogenesis of psychiatric disorders: genes, environment and behaviour. | Q36907357 | ||
| Linkage analysis followed by association show NRG1 associated with cannabis dependence in African Americans | Q36975926 | ||
| Neuregulin 1: a prime candidate for research into gene-environment interactions in schizophrenia? Insights from genetic rodent models | Q37096511 | ||
| Practitioner review: A critical perspective on gene-environment interaction models--what impact should they have on clinical perceptions and practice? | Q37126970 | ||
| Neuregulin 1 in neural development, synaptic plasticity and schizophrenia | Q37163033 | ||
| Gene-environment interactions affect long-term depression (LTD) through changes in dopamine receptor affinity in Snap25 deficient mice. | Q37170603 | ||
| Early life stress as a risk factor for mental health: role of neurotrophins from rodents to non-human primates | Q37216621 | ||
| The social defeat hypothesis of schizophrenia: an update | Q37228366 | ||
| Gene-environment interaction during early development in the heterozygous reeler mouse: clues for modelling of major neurobehavioral syndromes. | Q37290439 | ||
| Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression | Q37357632 | ||
| Early Cannabis Use, Polygenic Risk Score for Schizophrenia and Brain Maturation in Adolescence | Q37360523 | ||
| Experience sampling research in psychopathology: opening the black box of daily life | Q37392408 | ||
| The dystrobrevin binding protein 1 (DTNBP1) gene is associated with schizophrenia in the Irish Case Control Study of Schizophrenia (ICCSS) sample | Q37440662 | ||
| Schizophrenia and the city: A review of literature and prospective study of psychosis and urbanicity in Ireland | Q37629330 | ||
| REVIEW: Genome-wide findings in schizophrenia and the role of gene-environment interplay. | Q37765631 | ||
| Cognition and disability in bipolar disorder: lessons from schizophrenia research. | Q37773405 | ||
| Gene-environment interactions and construct validity in preclinical models of psychiatric disorders. | Q37822134 | ||
| Genetics of schizophrenia: new findings and challenges | Q37884607 | ||
| The size and burden of mental disorders and other disorders of the brain in Europe 2010. | Q37928182 | ||
| Cost of disorders of the brain in Europe 2010. | Q37933664 | ||
| Susceptibility genes for schizophrenia: mutant models, endophenotypes and psychobiology | Q37988447 | ||
| Genetic variation underlying psychosis-inducing effects of cannabis: critical review and future directions | Q38020213 | ||
| Risk genes for schizophrenia: translational opportunities for drug discovery | Q38190329 | ||
| Genetic risk for schizophrenia: convergence on synaptic pathways involved in plasticity | Q38242794 | ||
| Recent genetic findings in schizophrenia and their therapeutic relevance | Q38260258 | ||
| Closing the translational gap between mutant mouse models and the clinical reality of psychotic illness. | Q38330255 | ||
| Defeat stress in rodents: From behavior to molecules | Q38609722 | ||
| Are there sex differences in neuropsychological functions among patients with schizophrenia? | Q39476937 | ||
| Effects of family history and place and season of birth on the risk of schizophrenia | Q39487775 | ||
| Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids | Q39620533 | ||
| Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study | Q39680990 | ||
| Dissociation mediates the relationship between childhood trauma and hallucination-proneness | Q39710270 | ||
| The environment and schizophrenia | Q39958490 | ||
| A two-method meta-analysis of Neuregulin 1(NRG1) association and heterogeneity in schizophrenia | Q39988164 | ||
| Anxiety and substance use comorbidity among inpatients with schizophrenia | Q40599145 | ||
| Genetically mediated vulnerability to schizophrenia | Q40825750 | ||
| Loss of dysbindin-1, a risk gene for schizophrenia, leads to impaired group 1 metabotropic glutamate receptor function in mice. | Q41094422 | ||
| Bridging the gap between research into biological and psychosocial models of psychosis | Q41458505 | ||
| From real-world events to psychosis: the emerging neuropharmacology of delusions | Q41479982 | ||
| Meta-analysis of genetic variation in DTNBP1 and general cognitive ability | Q41951188 | ||
| Dysbindin modulates prefrontal cortical glutamatergic circuits and working memory function in mice. | Q42027886 | ||
| Adolescent cannabis exposure interacts with mutant DISC1 to produce impaired adult emotional memory. | Q42134009 | ||
| Phenotypic effects of maternal immune activation and early postnatal milieu in mice mutant for the schizophrenia risk gene neuregulin-1. | Q42208739 | ||
| Effect of maternal immune activation on the kynurenine pathway in preadolescent rat offspring and on MK801-induced hyperlocomotion in adulthood: amelioration by COX-2 inhibition | Q42215833 | ||
| Phenotypic effects of repeated psychosocial stress during adolescence in mice mutant for the schizophrenia risk gene neuregulin-1: a putative model of gene × environment interaction | Q42503597 | ||
| A follow-up study: acute behavioural effects of Delta(9)-THC in female heterozygous neuregulin 1 transmembrane domain mutant mice | Q42665096 | ||
| Transmembrane domain Nrg1 mutant mice show altered susceptibility to the neurobehavioural actions of repeated THC exposure in adolescence | Q42722527 | ||
| Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients | Q42724016 | ||
| The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids | Q42940472 | ||
| Nurr1 is required for maintenance of maturing and adult midbrain dopamine neurons | Q43218195 | ||
| Do transmembrane domain neuregulin 1 mutant mice exhibit a reliable sensorimotor gating deficit? | Q44449791 | ||
| Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia | Q44515032 | ||
| Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats | Q44530990 | ||
| Prenatal exposure to the 1957 influenza epidemic and adult schizophrenia: a follow-up study | Q45022278 | ||
| Neuregulin-1 immunoglobulin-like domain mutant mice: clozapine sensitivity and impaired latent inhibition | Q45261553 | ||
| Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring. | Q45399418 | ||
| Neuregulin-1 (NRG-1) and its susceptibility to schizophrenia: a case-control study and meta-analysis | Q45731580 | ||
| Neonatal polyI:C treatment in mice results in schizophrenia-like behavioral and neurochemical abnormalities in adulthood. | Q46008944 | ||
| Neuregulin 1 hypomorphic mutant mice: enhanced baseline locomotor activity but normal psychotropic drug-induced hyperlocomotion and prepulse inhibition regulation. | Q46033273 | ||
| Schizophrenia-related neural and behavioral phenotypes in transgenic mice expressing truncated Disc1. | Q46302011 | ||
| Psychosis-inducing effects of cannabis are related to both childhood abuse and COMT genotypes | Q46340259 | ||
| Behavioral abnormalities and dopamine reductions in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia. | Q46538656 | ||
| A novel protein isoform of catechol O-methyltransferase (COMT): brain expression analysis in schizophrenia and bipolar disorder and effect of Val158Met genotype | Q46772745 | ||
| Hypothesis: social defeat is a risk factor for schizophrenia? | Q46868838 | ||
| Brain derived Neurotropic Factor (BDNF) is associated with childhood abuse but not cognitive domains in first episode psychosis | Q46888485 | ||
| Heterozygous neuregulin 1 mice display greater baseline and Delta(9)-tetrahydrocannabinol-induced c-Fos expression. | Q46974480 | ||
| Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling | Q48131574 | ||
| Behavioral phenotypes of Disc1 missense mutations in mice | Q48178658 | ||
| Adult mice with reduced Nurr1 expression: an animal model for schizophrenia. | Q48189500 | ||
| Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia. | Q48268990 | ||
| Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults | Q48287666 | ||
| Post-pubertal emergence of disrupted latent inhibition following prenatal immune activation | Q48309581 | ||
| Neurobehavioural disorders in the infant reeler mouse model: interaction of genetic vulnerability and consequences of maternal separation. | Q48349616 | ||
| Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1. | Q48400355 | ||
| Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Delta9-tetrahydrocannabinol. | Q48411622 | ||
| The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. | Q48448425 | ||
| Advanced paternal age is associated with altered DNA methylation at brain-expressed imprinted loci in inbred mice: implications for neuropsychiatric disease. | Q48460645 | ||
| Social defeat interacts with Disc1 mutations in the mouse to affect behavior. | Q48485520 | ||
| Prenatal immune activation interacts with genetic Nurr1 deficiency in the development of attentional impairments. | Q48716701 | ||
| Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs | Q28296286 | ||
| DISC1-binding proteins in neural development, signalling and schizophrenia | Q28302106 | ||
| Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components | Q28585466 | ||
| Impaired long-term memory retention and working memory in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia | Q28756538 | ||
| Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress | Q29618764 | ||
| Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence | Q29618819 | ||
| Animal models of neuropsychiatric disorders | Q29619899 | ||
| Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions | Q29620063 | ||
| Schizophrenia. | Q30251961 | ||
| Animal models of gene-environment interaction in schizophrenia: A dimensional perspective. | Q30367009 | ||
| Partial genetic deletion of neuregulin 1 modulates the effects of stress on sensorimotor gating, dendritic morphology, and HPA axis activity in adolescent mice | Q30400033 | ||
| Effects of prenatal hypoxia on schizophrenia-related phenotypes in heterozygous reeler mice: a gene × environment interaction study | Q30405663 | ||
| Chronic exposure of mutant DISC1 mice to lead produces sex-dependent abnormalities consistent with schizophrenia and related mental disorders: a gene-environment interaction study | Q30413272 | ||
| Mouse models of gene-environment interactions in schizophrenia | Q30432026 | ||
| BDNF deficiency and young-adult methamphetamine induce sex-specific effects on prepulse inhibition regulation. | Q30453396 | ||
| Prenatal infection and schizophrenia: a review of epidemiologic and translational studies | Q30454666 | ||
| Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism | Q30454923 | ||
| The environment and susceptibility to schizophrenia | Q30459929 | ||
| Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways. | Q30465987 | ||
| Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice | Q30468504 | ||
| Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology | Q30472080 | ||
| Animal models of gene-environment interactions in schizophrenia | Q30478272 | ||
| Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background | Q30481233 | ||
| Interaction between environmental and genetic factors modulates schizophrenic endophenotypes in the Snap-25 mouse mutant blind-drunk | Q30485438 | ||
| Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans | Q30496743 | ||
| Dysbindin-1 loss compromises NMDAR-dependent synaptic plasticity and contextual fear conditioning | Q30573050 | ||
| Distinct phenotypes of new transmembrane-domain neuregulin 1 mutant mice and the rescue effects of valproate on the observed schizophrenia-related cognitive deficits | Q30576705 | ||
| Behavioral and molecular neuroepigenetic alterations in prenatally stressed mice: relevance for the study of chromatin remodeling properties of antipsychotic drugs | Q30823912 | ||
| Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression | Q33239430 | ||
| Basic concepts in the study of diseases with complex genetics | Q33544009 | ||
| Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia | Q33662873 | ||
| Development, disease and degeneration in schizophrenia: a unitary pathophysiological model | Q33813139 | ||
| Large-scale genomics unveils the genetic architecture of psychiatric disorders | Q33955116 | ||
| Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. | Q33963518 | ||
| A polymorphism in the dysbindin gene (DTNBP1) associated with multiple psychiatric disorders including schizophrenia | Q34025633 | ||
| A polygenic burden of rare disruptive mutations in schizophrenia | Q34060200 | ||
| Reelin-mediated signaling in neuropsychiatric and neurodegenerative diseases | Q34111923 | ||
| Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report | Q34137084 | ||
| Linking neurodevelopmental and synaptic theories of mental illness through DISC1 | Q34233683 | ||
| Gender differences in cognitive function of patients with chronic schizophrenia | Q34289627 | ||
| Paternal factors and schizophrenia risk: de novo mutations and imprinting | Q34356609 | ||
| Reduced dysbindin expression mediates N-methyl-D-aspartate receptor hypofunction and impaired working memory performance | Q34379851 | ||
| Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction | Q34415424 | ||
| Dysbindin and Schizophrenia: it's dopamine and glutamate all over again | Q34493312 | ||
| Therapeutic Potential of Cannabinoids in Psychosis. | Q34512679 | ||
| A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders | Q34561361 | ||
| Longitudinal study of stressful life events and daily stressors among adolescents at high risk for psychotic disorders | Q34604353 | ||
| DTNBP1 (dysbindin) gene variants modulate prefrontal brain function in schizophrenic patients--support for the glutamate hypothesis of schizophrenias | Q34617115 | ||
| Chronic adolescent exposure to Δ-9-tetrahydrocannabinol in COMT mutant mice: impact on psychosis-related and other phenotypes. | Q34660474 | ||
| Late Prenatal Immune Activation in Mice Leads to Behavioral and Neurochemical Abnormalities Relevant to the Negative Symptoms of Schizophrenia | Q34660546 | ||
| Toward the future of psychiatric diagnosis: the seven pillars of RDoC | Q34721927 | ||
| The poly(I:C)-induced maternal immune activation model in preclinical neuropsychiatric drug discovery | Q35538781 | ||
| Pathways to schizophrenia: the impact of environmental factors | Q35670625 | ||
| Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions | Q35677876 | ||
| DTNBP1 genotype influences cognitive decline in schizophrenia | Q35688111 | ||
| The Schizophrenia-Related Protein Dysbindin-1A Is Degraded and Facilitates NF-Kappa B Activity in the Nucleus | Q35690513 | ||
| D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHD. | Q35809256 | ||
| Chronic adolescent exposure to delta-9-tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathways | Q35982298 | ||
| Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice | Q36156959 | ||
| Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia | Q36167020 | ||
| Epigenetics of major psychosis: progress, problems and perspectives | Q36173922 | ||
| Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. | Q36189837 | ||
| Association between the neuregulin 1 gene and schizophrenia: a systematic review | Q36219044 | ||
| Implications of genetic findings for understanding schizophrenia | Q36245026 | ||
| Neurodevelopmental model of schizophrenia: update 2012 | Q36417310 | ||
| Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia. | Q36527680 | ||
| Stress, the hippocampus and the hypothalamic-pituitary-adrenal axis: implications for the development of psychotic disorders | Q36566937 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| gene-environment interaction | Q5533121 | ||
| P304 | page(s) | 2173748 | |
| P577 | publication date | 2016-01-01 | |
| 2016-09-20 | |||
| P1433 | published in | Neural Plasticity | Q15716605 |
| P1476 | title | Gene × Environment Interactions in Schizophrenia: Evidence from Genetic Mouse Models | |
| P478 | volume | 2016 |
| Q89939326 | Association Between Glutathione S-Transferase (GST) Polymorphisms and Schizophrenia in a Chinese Han Population |
| Q33819365 | Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research. |
| Q51765276 | Editorial: Brain Basis of Resilience and its Effect on Mood Disorders in the Aging. |
| Q38640149 | Interactions Between Variation in Candidate Genes and Environmental Factors in the Etiology of Schizophrenia and Bipolar Disorder: a Systematic Review |
| Q90289789 | Psychosocial Stress Induces Schizophrenia-Like Behavior in Mice With Reduced MMP-9 Activity |
| Q46096598 | Sensorimotor gating deficits in "two-hit" models of schizophrenia risk factors |
| Q38682213 | The impact of genetics on future drug discovery in schizophrenia |
| Q38699013 | Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies. |
Search more.